Gene Expression Changes in a Prefinal Health Stage of Lethally Irradiated Male and Female Rhesus Macaques.


Journal

Radiation research
ISSN: 1938-5404
Titre abrégé: Radiat Res
Pays: United States
ID NLM: 0401245

Informations de publication

Date de publication:
01 01 2023
Historique:
received: 15 03 2022
accepted: 24 10 2022
pubmed: 30 11 2022
medline: 12 1 2023
entrez: 29 11 2022
Statut: ppublish

Résumé

Radiation-induced gene expression (GE) changes can be used for early and high-throughput biodosimetry within the first three days postirradiation. However, is the method applicable in situations such as the Alexander Litvinenko case or the Goiania accident, where diagnosis occurred in a prefinal health stage? We aimed to characterize gene expression changes in a prefinal health stage of lethally irradiated male and female rhesus macaques. Peripheral blood was drawn pre-exposure and at the prefinal stage of male and female animals, which did not survive whole-body exposure with 700 cGy (LD66/60). RNA samples originated from a blinded randomized Good Laboratory Practice study comprising altogether 142 irradiated rhesus macaques of whom 60 animals and blood samples (15 samples for both time points and sexes) were used for this analysis. We evaluated GE on 34 genes widely used in biodosimetry and prediction of the hematological acute radiation syndrome severity (H-ARS) employing quantitative real-time polymerase chain reaction (qRT-PCR). These genes were run in duplicate and triplicate and altogether 96 measurements per time point and sex could be performed. In addition, 18S ribosomal RNA (rRNA) was measured to depict the ribosome/transcriptome status as well as for normalization purposes and 16S rRNA was evaluated as a surrogate for bacteremia. Mean differential gene expression (DGE) was calculated for each gene and sex including all replicate measurements and using pre-exposure samples as the reference. From 34 genes, altogether 27 genes appeared expressed. Pre-exposure samples revealed no signs of bacteremia and 18S rRNA GE was in the normal range in all 30 samples. Regarding prefinal samples, 46.7% and 40% of animals appeared infected in females and males, respectively, and for almost all males this was associated with out of normal range 18S rRNA values. The total number of detectable GE measurements was sixfold (females) and 15-fold (males) reduced in prefinal relative to pre-exposure samples and about tenfold lower in 80% of prefinal compared to pre-exposure samples (P < 0.0001). An overall 11-fold (median) downregulation in prefinal compared to pre-exposure samples was identified for most of the 27 genes and even FDXR appeared 4-14-fold downregulated in contrast to a pronounced up-regulation according to cited work. This pattern of overall downregulation of almost all genes and the rapid reduction of detectable genes at a prefinal stage was found in uninfected animals with normal range 18S rRNA as well. In conclusion, in a prefinal stage after lethal radiation exposure, the ribosome/transcriptome status remains present (based on normal range 18S rRNA values) in 60-67% of animals, but the whole transcriptome activity in general appears silenced and cannot be used for biodosimetry purposes, but probably as an indicator for an emerging prefinal health stage.

Identifiants

pubmed: 36445953
pii: 488817
doi: 10.1667/RADE-22-00083.1
doi:

Substances chimiques

RNA, Ribosomal, 18S 0
RNA, Ribosomal, 16S 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

17-24

Informations de copyright

© 2023 by Radiation Research Society. All rights of reproduction in any form reserved.

Auteurs

S Schüle (S)

Bundeswehr Institute of Radiobiology, Munich, Germany.

Z Gluzman-Poltorak (Z)

Neumedicines Inc, Pasadena, California.
Applied Stem Cell Therapeutics, Milpitas, California.

V Vainstein (V)

Neumedicines Inc, Pasadena, California.
Hadassah Medical Center, Jerusalem, Israel.

L A Basile (LA)

Neumedicines Inc, Pasadena, California.

M Haimerl (M)

Department of Radiology, University Hospital Regensburg, Regensburg, Germany.

C Stroszczynski (C)

Department of Radiology, University Hospital Regensburg, Regensburg, Germany.

M Majewski (M)

Bundeswehr Institute of Radiobiology, Munich, Germany.
Department of Urology, Armed Services Hospital Ulm, Ulm, Germany.

D Schwanke (D)

Bundeswehr Institute of Radiobiology, Munich, Germany.
Department of Urology, Armed Services Hospital Ulm, Ulm, Germany.

M Port (M)

Bundeswehr Institute of Radiobiology, Munich, Germany.

M Abend (M)

Bundeswehr Institute of Radiobiology, Munich, Germany.

P Ostheim (P)

Bundeswehr Institute of Radiobiology, Munich, Germany.
Department of Radiology, University Hospital Regensburg, Regensburg, Germany.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH